Takayuki Furuki
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Effects of sacubitril/valsartan according to daily salt intake and comparison with thiazide add-on treatment in patients with uncontrolled hypertension.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 03, 2025
Comparison of renal effects between sacubitril/valsartan and thiazide diuretics among patients with uncontrolled hypertension and chronic kidney disease in Japan.
Journal: Clinical and experimental nephrology
Published: May 10, 2025
Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan.
Journal: Journal of diabetes investigation
Published: April 13, 2025
Comparison between sacubitril/valsartan and thiazide diuretics among patients with uncontrolled hypertension in Japan.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: November 17, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
Journal: Diabetes, obesity & metabolism
Published: March 11, 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Journal: Frontiers in pharmacology
Published: December 20, 2023
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Journal: Diabetes & vascular disease research
Published: December 14, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 02, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Journal: Cardiovascular endocrinology & metabolism
Published: May 29, 2023
Cross-sectional survey of hypertension management in clinical practice in Japan: the Kanagawa Hypertension Study 2021 conducted in collaboration with Japan Medical Association Database of Clinical Medicine.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 02, 2023
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Journal: Scientific reports
Published: June 05, 2022
Last Updated: 09/26/2026